During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

An East Bay startup led by a former 23andMe exec snags $54.5 million to target a deadly kidney disease.

The human kidney is a masterclass in biological engineering. Responsible for filtering approximately 50 gallons of blood ...

Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

Long-term exposure to water contaminants, even below the regulatory limits, significantly increases the risk of chronic ...

Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Researchers conducted a post hoc analysis of the SURMOUNT-1 trial to assess the effect of tirzepatide on kidney function in prediabetes with obesity or overweight.

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

In this article Dr Kapil Thakkar covering causes, types, symptoms, diagnosis, treatment options of kidney stones (nephrolithiasis)—including diet, medication, and surgery—and strategies for recurrence ...